Two states, one week, counterfeit Botox everywhere. Texas and Ohio operations hit simultaneously in what regulators are calling a "coordinated enforcement action." If your toxin isn't coming through authorized distributors, this is your wake-up call.
New management services organization requirements target "corporate practice of medicine" arrangements. If you're running an MSO structure, your compliance window just got shorter.
A 312-patient study shows 94% satisfaction at 18 months with hyaluronic acid chin augmentation. The business case: higher margins, lower liability, repeat visits.
With the FDA escalating enforcement, here's how to verify your toxin and filler supply chain in under an hour. Pull these three documents and you're covered.